+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Completed

Age: 18Years +
All Genders
Healthy Volunteers
ID00001413

Bone Mineral Density in Patients With Major Depression With Melancholic and Atypical Features Relation to Stress-System Neurohormonal Function

Led by National Institute of Mental Health (NIMH) · Updated on 2017-07-02

585

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

The purpose of this study is to examine calcium absorption and bone mineral density in women with depression. Research indicates that pre-menopausal women with depression have significantly lower bone mineral density (BMD) than pre-menopausal women without depression. Although the mechanisms of BMD loss are unclear, researchers believe that individuals with depression have impaired calcium absorption. However, it is unknown whether the abnormal absorption is a result of depression or a side effect of the drugs used to treat it. This study will compare calcium absorption in women with depression and in healthy women without depression. Participants in this study will be given two non-radioactive calcium isotopes. One can be taken by mouth and the other must be injected. Participants will have the level of isotopes in their urine measured to estimate true fractional calcium absorption (TFCA). Participants may also have a dual X-ray absorptiometry (DEXA) scan to measure total body adiposity and lean body mass.

CONDITIONS

Brief Title

Bone Mineral Density in Women With Major Depression

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here